Prestige Consumer Healthcare (PBH) Times Interest Earned (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Times Interest Earned came in at $3.1 in Q4 2025, down 47.39% year-on-year from $5.89 in Q4 2024, and up 16.38% quarter-over-quarter from $2.66 in Q3 2025.
Prestige Consumer Healthcare (PBH) Times Interest Earned (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Times Interest Earned history runs 16 years deep, the most recent figure standing at $3.1 for Q4 2025.
- On a quarterly basis, Times Interest Earned fell 47.39% year-over-year to $3.1 in Q4 2025; TTM through Dec 2025 was $12.11, a 42.79% decrease from a year earlier, with the FY2025 full-year figure at $3.93, down 27.45% from the prior year.
- Times Interest Earned advanced to $3.1 in Q4 2025 per PBH's latest filing, from $2.66 in the prior quarter.
- Across five years, Times Interest Earned topped out at $8.07 in Q1 2023 and bottomed at -$2.5 in Q1 2025.
- The 5-year median for Times Interest Earned is $4.32 (2022), against an average of $3.49.
- Across the five-year window, Times Interest Earned plunged 211.74% in 2022 and surged 460.46% in 2023, its largest moves.
- Year by year, Times Interest Earned stood at $3.62 in 2021, then advanced by 18.79% to $4.3 in 2022, then increased by 21.91% to $5.24 in 2023, then climbed by 12.47% to $5.89 in 2024, then tumbled by 47.39% to $3.1 in 2025.
- Per Business Quant, the three latest PBH Times Interest Earned figures stand at $3.1 (Q4 2025), $2.66 (Q3 2025), and $2.51 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 13.44 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.81 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.18 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -0.07 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.33 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.11 |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 3.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.10 |
| Sep 30, 2025 | 2.66 |
| Jun 30, 2025 | 2.51 |
| Mar 31, 2025 | -2.50 |
| Dec 31, 2024 | 5.89 |
| Sep 30, 2024 | 5.37 |
| Jun 30, 2024 | 5.07 |
| Mar 31, 2024 | -1.76 |
| Dec 31, 2023 | 5.24 |
| Sep 30, 2023 | 5.01 |
| Jun 30, 2023 | 4.81 |
| Mar 31, 2023 | 8.07 |
| Dec 31, 2022 | 4.30 |
| Sep 30, 2022 | 5.13 |
| Jun 30, 2022 | 4.34 |
| Mar 31, 2022 | -2.24 |
| Dec 31, 2021 | 3.62 |
| Sep 30, 2021 | 3.81 |
| Jun 30, 2021 | 5.35 |
| Mar 31, 2021 | 2.00 |